Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,347.6
-1.1 (-0.03%)

 

  • STI Straits Times Index
    3,347.6
    -1.1 (-0.03%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,619.7
    -1.2 (-0.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,963.3
    -161.4 (-0.54%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,250.2
    -12.9 (-0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,090.1
    -187.9 (-0.84%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,507.2
    25.7 (0.40%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,213.8
    -32.1 (-1.43%)
    Index delayed 20 minutes
  • XAO XAO
    6,349.9
    -0.4 (-0.01%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 674.7M
  • Value: 928.5M
  • Rise: 133
  • Fall: 191
  • Unch: 521

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Genting Sing0.960-
TEE Intl0.113-0.001
Mapletree Log Tr1.440-
YZJ Shipbldg SGD1.600+0.010
Ascendas Reit2.940-
JCG Investment0.002-
Golden Agri-Res0.295-0.010
CapitaMall Trust2.310-0.020
Y Ventures0.135+0.016
ESR-REIT0.515-0.005

World Indices

World Indices
Name Last Change
Nasdaq 7,996.1 -4.2
HSI 29,963.3 -161.4
HSCEI 11,768.6 -80.3
Jakarta 6,507.2 +25.7
Nikkei 225 22,090.1 -187.8
SSE Comp 3,250.2 -12.9
Shanghai A 3,404.3 -13.6
Shanghai B 319.0 +0.9
ShenZhen A 1,843.2 -10.9
ShenZhen B 1,059.0 +1.9
Taiwan W 10,962.0 -35.2
PSE Comp 0.0
KOSPI 2,213.8 -32.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Annica ANNICA HOLDINGS LIMITED
Quotes 10 Minutes Delayed. Updated at 18 Apr 2019 16:40
Last (SGD): 0.001 Change: - High: 0.001 Remarks: -
Change (%): - Low: 0.001
Open 0.001 Yesterday's Close 0.001
Buy Price - Sell Price 0.001
Buy Volume ('000) - Sell Volume ('000) 235,023.0
Cumulative Volume ('000) 2,800.0 Cumulative Value 2,800
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.00025 Trailing EPS (SGD) e -0.00025 NAV (SGD) b 0.0003
PE a - Trailing PE f - Price / NAV b 3.3333
Dividend (SGD) d - Cash In Hand (SGD) g 0.0001 Issued & Paid-up Shares c 16,174,767,000
Dividend Yield (%) d - Price / Cash In Hand g 10.000 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 16.175
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 15.390
Piotroski F Score 2 Exchange Code 5AL Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 0.0 6-Month VWAP 0.001 Free Float (%) -
Under CPF Investment Scheme (CPFIS) Yes
Sector & Industry Manufacturing - Medical Specialties
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Apr 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Annica SGX 16.175 - - 3.3333 -
Industry Medical Specialties SGX 659.101 31.151 31.424 3.8700 1.849
Index FTSE ST Catalist Index SGX 81.312 131.623 - 0.9313 2.238
Local Peer Top Glove SGX 3,789.661 26.246 26.340 4.5891 1.918
Local Peer Biolidics SGX 71.537 - - 5.6950 -
Local Peer UG Healthcare SGX 35.953 8.292 9.585 0.8579 1.252
Local Peer Yunnan Energy SGX 26.442 - - 0.5069 -
Local Peer Medtecs Intl SGX 14.834 11.894 11.896 0.1744 -
Global Peer ABBOTT LABORATORIES NYSE 128,011.534 54.403 54.404 4.1938 1.591
Global Peer MEDTRONIC PLC NYSE 113,635.640 36.609 23.101 2.2805 2.288
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 102,995.245 35.056 35.056 3.7336 0.285
Global Peer DANAHER CORP NYSE 89,375.867 33.715 33.715 3.1677 0.502
Global Peer STRYKER CORP NYSE 67,248.445 18.927 18.927 5.7330 1.075
Global Peer BECTON DICKINSON & CO NYSE 60,773.260 382.222 67.903 2.8396 1.333
Global Peer INTUITIVE SURGICAL INC NASDAQ 60,564.525 53.697 53.697 9.0682 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 48,542.355 29.050 29.050 5.5630 -
Global Peer BAXTER INTERNATIONAL INC NYSE 38,021.994 23.413 23.413 4.8784 0.985
Global Peer EDWARDS LIFESCIENCES CORP NYSE 36,937.266 51.145 51.145 11.7619 -
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WATERS CORP (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), RESMED INC (NYSE), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), HOLOGIC INC (NASDAQ), VARIAN MEDICAL SYSTEMS INC (NYSE), ABIOMED INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), PERKINELMER INC (NYSE), STERIS PLC (NYSE), DEXCOM INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), QIAGEN NV (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COCHLEAR LTD (ASX), MASIMO CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), INSULET CORPORATION (NASDAQ), ICU MEDICAL INC (NASDAQ), PENUMBRA INC (NYSE), WEIGAO GROUP (HKEx), GLOBUS MED INC (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HAEMONETICS CORP (NYSE), NOVOCURE LTD (NASDAQ), HARTA (Bursa), WRIGHT MEDICAL GROUP NV (NASDAQ), LIVANOVA PLC (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NEOGEN CORP (NASDAQ), NUVASIVE INC (NASDAQ), TOPGLOV (Bursa), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), QUIDEL CORP (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NASDAQ), AVANOS MEDICAL INC (NYSE), NEVRO CORP (NYSE), BIOTELEMETRY INC (NASDAQ), INOGEN INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), ATRION CORP (NASDAQ), MICROPORT (HKEx), STAAR SURGICAL CO (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), CAREDX INC (NASDAQ), ATRICURE INC (NASDAQ), CRYOLIFE INC (NYSE), ORTHOFIX MEDICAL INC (NASDAQ), NANOSONICS LIMITED (ASX), SILK ROAD MEDICAL INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), LIFETECH SCI (HKEx), FLUIDIGM CORP DEL (NASDAQ), CIRC (HKEx), MESA LABORATORIES INC (NASDAQ), AXOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), CERUS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VERICEL CORP (NASDAQ), VIEWRAY INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), HESKA CORP (NASDAQ), YESTAR HEALTH (HKEx), AK MEDICAL (HKEx), QUOTIENT LTD (NASDAQ), SURMODICS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), CORMEDIX INC (NYSE American), SUPERMX (Bursa), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), CORINDUS VASCULAR ROBOTICS INC (NYSE American), SI BONE INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), VAPOTHERM INC (NYSE), GOLDEN MEDITECH (HKEx), IRADIMED CORP (NASDAQ), NEURONETICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), PW MEDTECH (HKEx), MEDICAL DEVELOPMENT INTL (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), AVID BIOSERVICES INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), INVACARE CORP (NYSE), CUTERA INC (NASDAQ), INTRICOM CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SIENTRA INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), AVEDRO INC (NASDAQ), CRH MEDICAL CORP (NYSE American), SOLITON INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CONFORMIS INC (NASDAQ), NUVECTRA CORPORATION (NASDAQ), ZYNEX INC (NASDAQ), ELECTROCORE INC (NASDAQ), MODERN DENTAL (HKEx), MISONIX INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), BIOTIME INC (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), FONAR CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), ONCOCYTE CORP (NYSE American), BIOSIG TECHNOLOGIES INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), YUNNAN ENERGY (HKEx), MOTUS GI HOLDINGS INC (NASDAQ), SOMNOMED LIMITED (ASX), APOLLO ENDOSURGERY INC (NASDAQ), CAS MEDICAL SYSTEMS (NASDAQ), SDI LTD (ASX), NEUROTROPE INC (NASDAQ), IRIDEX CORP (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), ENDOLOGIX INC (NASDAQ), CYCLOPHARM LIMITED (ASX), ZOSANO PHARMA CORP (NASDAQ), COMPUMEDICS (ASX), XTANT MEDICAL HLDGS INC (NYSE American), IMPEDIMED LIMITED (ASX), ALPHA PRO TECH (NYSE American), VINCENT MED (HKEx), RA MEDICAL SYSTEMS INC (NYSE), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ELECTROMED INC (NYSE American), BIOLASE INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), CELSION CORPORATION (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), IMMUCELL CORP (NASDAQ), DAXOR CORP (NYSE American), RESONANCE HEALTH LTD (ASX), MICRO-X LTD (ASX), RESPIRI LTD (ASX), INSPIREMD INC (NYSE American), PAVMED INC (NASDAQ), LIFE HEALTHCARE (HKEx), TITAN MEDICAL INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), AVINGER INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), NEOVASC INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), RESTORATION ROBOTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), ADMEDUS LTD (ASX), OBJ LIMITED (ASX), LIANLUO SMART LIMITED (NASDAQ), ATOSSA GENETICS INC (NASDAQ), BIOMERICA INC (NASDAQ), PRECISION THERAPEUTICS INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CHECK-CAP LTD (NASDAQ), CYANOTECH CORP (NASDAQ), CARDIEX LTD (ASX), REALM THERAPEUTICS PLC SPONSORED ADS (NASDAQ), COMBEST HOLD (HKEx), DYNATRONICS CORP (NASDAQ), OVENTUS MEDICAL LTD (ASX), EMVISION MEDICAL DEVICES LTD (ASX), USCOM LTD (ASX), HUAKANG BIOMED (HKEx), DIGIRAD CORP (NASDAQ), AETHLON MEDICAL (NASDAQ), ADVENTA (Bursa), MILESTONE SCIENTIFIC INC (NYSE American), OBALON THERAPEUTICS INC (NASDAQ), LKL (Bursa), OPTISCAN IMAGING (ASX), ANALYTICA (ASX), REWALK ROBOTICS LTD (NASDAQ), DIMERIX LTD (ASX), TENAX THERAPEUTICS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), PRESBIA PLC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), MICRON SOLUTIONS INC (NYSE American), ALLEGRA ORTHOPAEDICS LIMITED (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), CESCA THERAPEUTICS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), CH DEMETER FIN (HKEx), SINTX TECHNOLOGIES INC (NASDAQ), ADHERIUM LIMITED (ASX), METALICITY LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGARD LIMITED (ASX), STHAI (SET), MY MEDICARE (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months ---
6 Months ---
1 Year ---
Long Term Return 2 Years ---
3 Years --0.001
-50.00 %
5 Years --0.009
-90.00 %
Annualised Return Annualised --
-36.90 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.001 - 0.001 Change From 1 Year Low - % Change From 1 Year Low (%) -
Change From 1 Year High - % Change From 1 Year High (%) -
2 Years Range 0.001 - 0.001 Change From 2 Years Low - % Change From 2 Years Low (%) -
Change From 2 Years High - % Change From 2 Years High (%) -
5 Years Range 0.001 - 0.017 Change From 5 Years Low - % Change From 5 Years Low (%) -
Change From 5 Years High -0.016 % Change From 5 Years High (%) -94.12
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company was incorporated in Singapore on 20 August 1983. On 20 March 2001, it was converted into a public limited company at which time it changed its name to Oculus Limited. It is focused on the innovation, manufacturing and marketing of colour lenses. Its colour lenses are principally marketed under the FreshKon® and Unicon™ brand names globally. Aside from colour lenses, Oculus also offers disposable daily clear lenses, disposable bi-weekly and monthly clear lenses under FreshKon® brand, and gas permeable lenses and solution under the Boston® brand to its broad customer base.With direct presence in Singapore, China, Taiwan, Hong Kong and Malaysia, its products are sold in over 50 countries globally.

IPO Performance

Listing Date 11 Apr 2001 Full Subscription Rate (x) 1.03
No of Placement Shares (M) 19.76 No of Public Offer Shares (M) 2.20 Public Offer Subscription Rate (x) 1.29
IPO Price (SGD) a 0.193 First Day Close (SGD) a 0.160 First Week Close (SGD) a 0.168
Current vs IPO Price (%) -99.48 First Day Gain (%) -17.10 First Week Gain (%) -12.95
Notes:
  1. Adjusted for the following: Rights Issue 1 for 1 @ $0.015 on 14/12/2012

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(4.40 MB)
Annual Report 2017 Dec 2017 Part 1(0.03 MB)
Part 2(0.31 MB)
Part 3(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(0.53 MB)
Annual Report 2015 Dec 2015 Part 1(1.96 MB)
Annual Report 2014 Dec 2014 Part 1(0.78 MB)
Annual Report 2013 Dec 2013 Part 1(0.61 MB)
Annual Report 2012 Dec 2012 Part 1(0.33 MB)
Annual Report 2011 Dec 2011 Part 1(0.28 MB)
Annual Report 2010 Dec 2010 Part 1(1.97 MB)
Annual Report 2009 Dec 2009 Part 1(0.02 MB)
Part 2(0.37 MB)
Annual Report 2008 Dec 2008 Part 1(0.45 MB)
Annual Report 2007 Dec 2007 Part 1(0.70 MB)
Annual Report 2006 Dec 2006 Part 1(1.12 MB)
Annual Report 2005 Dec 2005 Part 1(6.97 MB)
IPO Prospectus
IPO Prospectus 2001 Mar 2001 Part 1(2.58 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
18 Apr 2019 0.001 0.001 0.001 0.001 2,800,000 0.0010
17 Apr 2019 0.001 0.001 0.001 0.001 - -
16 Apr 2019 0.001 0.001 0.001 0.001 - -
15 Apr 2019 0.001 0.001 0.001 0.001 - -
12 Apr 2019 0.001 0.001 0.001 0.001 - -
11 Apr 2019 0.001 0.001 0.001 0.001 - -
10 Apr 2019 0.001 0.001 0.001 0.001 - -
09 Apr 2019 0.001 0.001 0.001 0.001 - -
08 Apr 2019 0.001 0.001 0.001 0.001 - -
05 Apr 2019 0.001 0.001 0.001 0.001 - -
04 Apr 2019 0.001 0.001 0.001 0.001 - -
03 Apr 2019 0.001 0.001 0.001 0.001 - -
02 Apr 2019 0.001 0.001 0.001 0.001 2,000,100 0.0010
01 Apr 2019 0.001 0.001 0.001 0.001 100 0.0010
29 Mar 2019 0.001 0.001 0.001 0.001 100 0.0010
28 Mar 2019 0.001 0.001 0.001 0.001 100 0.0010
27 Mar 2019 0.001 0.001 0.001 0.001 100 0.0010
26 Mar 2019 0.001 0.001 0.001 0.001 100 0.0010
25 Mar 2019 0.001 0.001 0.001 0.001 100 0.0010
22 Mar 2019 0.001 0.001 0.001 0.001 100 0.0010
21 Mar 2019 0.001 0.001 0.001 0.001 100 0.0010
20 Mar 2019 0.001 0.001 0.001 0.001 100 0.0010
Summary
Current 2 Weeks
(05 Apr 2019 to 18 Apr 2019)
0.001 0.001 0.001 0.001 2,800,000 -
Previous 2 Weeks
(22 Mar 2019 to 04 Apr 2019)
0.001 0.001 0.001 0.001 2,000,800 -
4 Weeks from
(22 Feb 2019 to 21 Mar 2019)
0.001 0.001 0.001 0.001 3,001,200 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.